Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Theres emerging evidence that GLP-1 receptor activation influences dopamine signaling in these circuits, which raises the question of whether semaglutide might affect ADHD symptoms independently of its weight loss effects
Eli Lillys Orforglipron Hits Target in Diabetes TrialOral GLP-1 Battle with Novo Nordisk Heats Up Key Takeaways 10.5% average weight loss in overweight/obese patients with Type 2 diabetes over ~72 weeks on orforglipron
Unlike semaglutide, which targets only GLP-1 receptors, tirzepatide activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Set points, settling points, and the control of body weight
NAC may theoretically affect platelet function
Its only been about 2 weeks so I havent weighed myself yet, but I definitely look less blah and more shapely
